Winners of the Nanotechnology Startup Challenge in Cancer Announced!
The Center for Advancing Innovation and the National Institutes of Health's National Cancer Institute partnered for the Nanotechnology Startup Challenge in Cancer (NSC2). Congratulations to the winners and finalists! The teams are listed here that intend to bring the promising cancer nanotechnology inventions forward.
NCI Alliance Phase II (2010-15) Program Summary Now Available!
The National Cancer Institute Office of Cancer Nanotechnology Research has released the 2010-2015 Alliance Phase II Program Summary. This summary highlights the scientific and translational advances generated by all components of the Alliance during the past 5-year funding period. Visit here to download this summary for free.
Cancer Nanotechnology Plan 2015 Now Available to Download!
The National Cancer Institute Office of Cancer Nanotechnology Research has released the 2015 edition of the Cancer Nanotechnology Plan. Written by multiple leaders from across academic, private, and government sectors, the CaNanoPlan gives the strategic vision of the field's current state and its potential future. Since its last edition in 2010, this 2015 edition has greatly expanded covering over 35 topical areas in this field. Visit here to download this latest edition for free.
NCI caNanoLab 2.0 Launched!
The National Cancer Institute Office of Cancer Nanotechnology Research and NCI Center for Biomedical Informatics and Information Technology have completed initial enhancements to improve usability of the caNanoLab data portal, which is now deployed as caNanoLab 2.0. To learn more about the enhancements and provide feedback, visit the caNanoLab Usability Discussion Forum.
NCI Alliance Funding Opportunity for IRCN Projects Reissued March 2017
The National Cancer Institute is pleased to announce the reissuance of the funding opportunity (PAR-17-240) for Innovative Research in Cancer Nanotechnology (IRCN) applications, through the Alliance for Nanotechnology in Cancer program. The IRCN FOA will have two receipt dates per year through 2020 and projects should be designed to enable multidisciplinary, fundamental research in cancer biology and/or oncology through the use of nanotechnology.
Receipt dates for the new IRCN (R01) as well as the CNTCs (T32) remain and are funded through the following announcements and dates:
Learn more about other research funding opportunities.
Learn more about current Alliance for Nanotechnology in Cancer awardees and their project descriptions.
Image Credentials: Ye Yuan Ph.D.; Graduate Student William Liu M.S.; Research Associate Professor, Tatjana Paunesku Ph.D.; and Professor Gayle E. Woloschak Ph.D., Northwestern University and Si Chen Ph.D. and Stefan Vogt Ph.D, Advanced Photon Source.
View our Image Library